It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 | Hyderabad, Telangana, India | ActiveSakksa Pharma Private Limited, a active private limited company, was established on 12 December 2019 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304TG2019PTC137524. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Sureshbabu Makam (Director), Javvaji Devi Aruna (Additional Director), Javvaji Anil Kumar Gupta (Director). Past directors included Anjali Patidar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.576, Flat No.302, Ananda Nilayam Near Bsnl Exchange, Mig2, Kphb Colony, Hyderabad, Telangana, 500085.
U24304TG2019PTC137524
137524
12 December 2019
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sakksa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sureshbabu Makam | Director | 12 Dec 2019 | Current |
| Javvaji Devi Aruna | Additional Director | 09 Jan 2021 | Current |
| Javvaji Anil Kumar Gupta | Director | 12 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sakksa Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 111.41% decrease in profit. The company's net worth Soared by an impressive increase of 1267.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sakksa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sakksa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sakksa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sakksa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sakksa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Sakksa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity Javvaji Devi Aruna was appointed as a Additional Director was appointed as a Additional Director on 09 Jan 2021 & has been associated with this company since 5 years 4 days . was completed.
The activity Sureshbabu Makam was appointed as a Director was appointed as a Director on 12 Dec 2019 & has been associated with this company since 6 years 1 month . was completed.
Progress on Javvaji Anil Kumar Gupta was appointed as a Director was appointed as a Director on 12 Dec 2019 & has been associated with this company since 6 years 1 month . was documented.
Sakksa Pharma Private Limited was registered on 12 Dec 2019 with Roc Hyderabad & aged 6 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Sakksa Pharma Private Limited is U24304TG2019PTC137524.
Sakksa Pharma Private Limited is headquartered at Plot No.576, Flat No.302, Ananda Nilayam Near Bsnl Exchange, Mig2, Kphb Colony, Hyderabad, Telangana, 500085.
Sakksa Pharma Private Limited was incorporated on 12 December 2019.
The current directors of Sakksa Pharma Private Limited are
The primary industry of Sakksa Pharma Private Limited is Manufacturing.
Sakksa Pharma Private Limited is unlisted.
The authorized capital of Sakksa Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX